Prognostic utility of novel biomarkers in acute-on-chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study.

Ruihong ZhaoWei WuZhibo ZhouXiaoqing ZhengWenjie SunYemin ShiHaiying YuFang WangHong ZhaoShanshan SunLinfeng JinJifang ShengYu Shi

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2018)

Soluble CD163 and NGAL are independently associated with short-term mortality in hepatitis B-associated ACLF. Use of a combination of sCD163 and NGAL improves prognostication.

Keyphrases

liver failure
hepatitis b virus
cardiovascular events
cross sectional
risk factors
nk cells
double blind
coronary artery disease
type diabetes
drug induced
cardiovascular disease